Emergency Use Authority and 2009 H1N1 influenza

Area of Science:

• Public Health
• Regulatory Science
• Emergency Preparedness

Background:

• The Federal Food, Drug and Cosmetic Act provides a framework for product authorization during public health emergencies.
• The Department of Health and Human Services (HHS) is responsible for implementing these emergency provisions.
• The H1N1 influenza pandemic presented a critical need for timely access to medical countermeasures.

Purpose of the Study:

• To detail the procedural steps HHS follows to issue Emergency Use Authorizations (EUAs).
• To provide context and examples of situations necessitating EUAs.
• To list specific products authorized under EUAs for the H1N1 influenza pandemic as of September 1, 2009.

Main Methods:

• Review of regulatory pathways established by Section 564 of the Federal Food, Drug and Cosmetic Act.
• Analysis of HHS decision-making criteria for emergency use authorization.
• Compilation of authorized products and their indications during the H1N1 pandemic.

Main Results:

• The article describes the multi-step process for granting EUAs by HHS.
• Examples illustrate scenarios where EUAs are deemed appropriate.
• A specific list of products authorized for H1N1 influenza is provided.

Conclusions:

• HHS utilizes EUAs under Section 564 to expedite access to critical medical products during declared emergencies.
• The EUA process balances public health needs with regulatory oversight.
• Understanding the EUA framework is crucial for pandemic preparedness and response.